{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:10:47Z","timestamp":1760184647759,"version":"build-2065373602"},"reference-count":59,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Rheumatic Disease Clinics of North America"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.rdc.2023.01.013","type":"journal-article","created":{"date-parts":[[2023,4,5]],"date-time":"2023-04-05T22:10:09Z","timestamp":1680732609000},"page":"425-444","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Training the Next Generation of Rheumatologists"],"prefix":"10.1016","volume":"49","author":[{"given":"Tatiana S.","family":"Rodr\u00edguez-Reyna","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faye N.","family":"Hant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurizio","family":"Cutolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rdc.2023.01.013_bib1","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1002\/art.11073","article-title":"Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population","volume":"48","author":"Mayes","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2023.01.013_bib2","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","article-title":"2013 classification criteria for systemic sclerosis: an American college of rheumatology\/European league against rheumatism collaborative initiative","volume":"72","author":"van den Hoogen","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2023.01.013_bib3","series-title":"Scleroderma","first-page":"39","article-title":"Disease Subsets in Clinical Practice","author":"Domsic","year":"2017"},{"key":"10.1016\/j.rdc.2023.01.013_bib4","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s12016-018-8718-8","article-title":"Antinuclear antibodies in systemic sclerosis: an update","volume":"58","author":"Stochmal","year":"2020","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.rdc.2023.01.013_bib5","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1177\/2397198318783930","article-title":"Anti-nuclear autoantibodies in systemic sclerosis: news and perspectives","volume":"3","author":"Hamaguchi","year":"2018","journal-title":"J\u00a0Scleroderma Relat Disord"},{"key":"10.1016\/j.rdc.2023.01.013_bib6","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1097\/BOR.0000000000000550","article-title":"An update on autoantibodies in scleroderma","volume":"30","author":"Mecoli","year":"2018","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.rdc.2023.01.013_bib7","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.autrev.2018.01.006","article-title":"Bicaudal D2 is a novel autoantibody target in systemic sclerosis that shares a key epitope with CENP-A but has a distinct clinical phenotype","volume":"17","author":"Fritzler","year":"2018","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.rdc.2023.01.013_bib8","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1002\/acr.23763","article-title":"Anti-RNPC-3 (U11\/U12) antibodies in systemic sclerosis in patients with moderate-to-severe gastrointestinal dysmotility","volume":"71","author":"McMahan","year":"2019","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.rdc.2023.01.013_bib9","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/acr.22163","article-title":"Autoantibodies to RuvBL1 and RuvBL2: a novel systemic sclerosis related antibody associated with diffuse cutaneous and skeletal muscle involvement","volume":"66","author":"Kaji","year":"2014","journal-title":"Arthritis Care Res"},{"issue":"2Suppl71","key":"10.1016\/j.rdc.2023.01.013_bib10","first-page":"S12","article-title":"Anti-PM-Scl antibody in patients with systemic sclerosis","volume":"30","author":"Koschik","year":"2012","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.rdc.2023.01.013_bib11","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.3899\/jrheum.110071","article-title":"Anti-fibrillarin antibody in African American patients with systemic sclerosis: immunogenetics, clinical features and survival analysis","volume":"38","author":"Sharif","year":"2011","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2023.01.013_bib12","doi-asserted-by":"crossref","first-page":"576","DOI":"10.3109\/08916934.2011.592886","article-title":"Distinctive autoantibody profile in Mexican Mestizo Systemic Sclerosis Patients","volume":"44","author":"Rodriguez-Reyna","year":"2011","journal-title":"Autoimmunity"},{"key":"10.1016\/j.rdc.2023.01.013_bib13","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1002\/art.24586","article-title":"Anti-U11\/U12 RNP antibodies in systemic sclerosis: a new serologic marker associated with pulmonary fibrosis","volume":"61","author":"Fertig","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2023.01.013_bib14","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/art.24409","article-title":"Anti-U3 RNP autoantibodies in systemic sclerosis","volume":"60","author":"Aggarwal","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2023.01.013_bib15","first-page":"104","article-title":"Disease subsets, antinuclear antibody profile, and clinical features in 127 French and 247\u00a0US adult patients with systemic sclerosis","volume":"34","author":"Meyer","year":"2007","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2023.01.013_bib16","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/art.10760","article-title":"A\u00a0comparison between anti-Th\/To and anticentromere antibody-positive systemic sclerosis patients with limited cutaneous involvement","volume":"48","author":"Mitri","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2023.01.013_bib17","first-page":"639","article-title":"Isolated pulmonary hypertension in systemic sclerosis with diffuse cutaneous involvement: association with serum anti-U3-RNP antibody","volume":"23","author":"Sacks","year":"1996","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2023.01.013_bib18","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.7326\/0003-4819-119-10-199311150-00007","article-title":"Autoantibody reactive with RNA polymerase III in systemic sclerosis","volume":"119","author":"Okano","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.rdc.2023.01.013_bib19","doi-asserted-by":"crossref","first-page":"355","DOI":"10.2217\/ijr.10.17","article-title":"Raynaud's phenomenon and digital ischemia: a practical approach to risk stratification, diagnosis and management","volume":"5","author":"McMahan","year":"2010","journal-title":"Int J Clin Rheumtol"},{"key":"10.1016\/j.rdc.2023.01.013_bib20","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1136\/ard.2006.066068","article-title":"Changes in causes of death in systemic sclerosis, 1972-2002","volume":"66","author":"Steen","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2023.01.013_bib21","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.semarthrit.2019.02.005","article-title":"Myocardial fibrosis detected by magnetic resonance imaging, elevated U-CRP and higher mRSS are predictors of cardiovascular complications in systemic sclerosis patients","volume":"49","author":"Rodriguez-Reyna","year":"2019","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.rdc.2023.01.013_bib22","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1002\/art.24730","article-title":"Reliability and validity of the University of California, Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument","volume":"61","author":"Khanna","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2023.01.013_bib23","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/0002-9343(84)90986-0","article-title":"Factors predicting development of renal involvement in progressive systemic sclerosis","volume":"76","author":"Steen","year":"1984","journal-title":"Am J Med"},{"key":"10.1016\/j.rdc.2023.01.013_bib24","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1002\/1529-0131(199809)41:9<1613::AID-ART11>3.0.CO;2-O","article-title":"Case-control study of corticosteroids and other drugs that either precipitate or protect from the development of scleroderma renal crisis","volume":"41","author":"Steen","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2023.01.013_bib25","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.rdc.2015.04.008","article-title":"Scleroderma Renal Crisis","volume":"41","author":"Guillevin","year":"2015","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.rdc.2023.01.013_bib26","first-page":"keac361","article-title":"Clinico-pathological phenotypes of Systemic Sclerosis related myopathy: analysis of a multicenter larger cohort","author":"Matas-Garc\u00eda","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.rdc.2023.01.013_bib27","doi-asserted-by":"crossref","first-page":"117421","DOI":"10.1016\/j.jns.2021.117421","article-title":"Peripheral nervous system manifestations of rheumatological diseases","volume":"424","author":"Gwathmey","year":"2021","journal-title":"J\u00a0Neurol Sci"},{"key":"10.1016\/j.rdc.2023.01.013_bib28","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1002\/acr.20187","article-title":"Psychological health and well-being in systemic sclerosis: State of the science and consensus research agenda","volume":"62","author":"Thombs","year":"2010","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.rdc.2023.01.013_bib29","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.rdc.2015.04.010","article-title":"Psychosocial aspects of scleroderma","volume":"41","author":"Kwakkenbos","year":"2015","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.rdc.2023.01.013_bib30","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1177\/2397198320921044","article-title":"Assessment of skin disease in scleroderma: practices and opinions of investigators studying scleroderma","volume":"5","author":"Showalter","year":"2020","journal-title":"J\u00a0Scleroderma Relat Disord"},{"key":"10.1016\/j.rdc.2023.01.013_bib31","doi-asserted-by":"crossref","first-page":"791","DOI":"10.3899\/jrheum.160654","article-title":"Reliability and validity of the tender and swollen joint counts and the modified rodnan skin score in early diffuse cutaneous systemic sclerosis: analysis from the prospective registry of early systemic sclerosis cohort","volume":"44","author":"Gordon","year":"2017","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2023.01.013_bib32","doi-asserted-by":"crossref","first-page":"11","DOI":"10.5301\/jsrd.5000231","volume":"2","author":"Khanna","year":"2017","journal-title":"J\u00a0Scleroderma Relat Disord"},{"key":"10.1016\/j.rdc.2023.01.013_bib33","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1111\/1756-185X.13523","article-title":"Evaluation of Scleroderma Clinical Trials consortium training recommendations on modified Rodnan skin scores assessment in scleroderma","volume":"22","author":"Low","year":"2019","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.rdc.2023.01.013_bib34","series-title":"Case studies in systemic sclerosis","first-page":"299","article-title":"Chapter 32: a dentist inquires about his patient with systemic sclerosis","author":"Hant","year":"2011"},{"key":"10.1016\/j.rdc.2023.01.013_bib35","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.1002\/art.24038","article-title":"Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis","volume":"58","author":"Koenig","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2023.01.013_bib36","first-page":"102","article-title":"Ulnar artery involvement in systemic sclerosis (scleroderma)","volume":"29","author":"Taylor","year":"2002","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2023.01.013_bib37","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1002\/art.1780400620","article-title":"The palpable tend\u00f3n friction rub: an important physical examination finding in patients with systemic sclerosis","volume":"40","author":"Steen","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2023.01.013_bib38","first-page":"1573","article-title":"Criteria for the classification of early Systemic Sclerosis","volume":"28","author":"LeRoy","year":"2001","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2023.01.013_bib39","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/ard.2010.136929","article-title":"Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group","volume":"70","author":"Avouac","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2023.01.013_bib40","doi-asserted-by":"crossref","first-page":"e834","DOI":"10.1016\/S2665-9913(21)00244-7","article-title":"Progression of patients with Raynaud's Phenomenon to systemic sclerosis: a five-year analysis of the European Scleroderma Trial and Research group multicentre, longitudinal registry study for Very Early Diagnosis of Systemic Sclerosis (VEDOSS)","volume":"3","author":"Bellando-Randone","year":"2021","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.rdc.2023.01.013_bib41","article-title":"Is there a link between nailfold videocapillaroscopy and pulmonary function tests in systemic sclerosis patients? A 24-month follow-up monocentric study","author":"Silva-Viela","year":"2021","journal-title":"J\u00a0Clin Rheumatol"},{"key":"10.1016\/j.rdc.2023.01.013_bib42","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3899\/jrheum.140276","article-title":"Association between nailfold capillaroscopy findings and pulmonary function tests in patients with Systemic Sclerosis","volume":"42","author":"Castellvi","year":"2015","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2023.01.013_bib43","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1002\/art.39718","article-title":"Nailfold videocapillaroscopic features and other clinical risk factors for digital ulcers in Systemic sclerosis","volume":"68","author":"Cutolo","year":"2016","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2023.01.013_bib44","first-page":"688","article-title":"Capillaroscopic skin ulcer risk index: a new prognostic tool for digital skin ulcer development in systemic sclerosis patients","volume":"621","author":"Sebastiani","year":"2009","journal-title":"Arthritis Rheum (Arthritis Care Research)"},{"key":"10.1016\/j.rdc.2023.01.013_bib45","doi-asserted-by":"crossref","first-page":"102458","DOI":"10.1016\/j.autrev.2020.102458","article-title":"Standardisation of nailfold capillaroscopy for the assessment of patients with Raynaud's phenomenon and systemic sclerosis","volume":"19","author":"Smith","year":"2020","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.rdc.2023.01.013_bib46","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1007\/s10067-019-04610-5","article-title":"Pan-American League of Associations for Rheumatology (PANLAR) capillaroscopy study group consensus for the format and content of the report in capillaroscopy in rheumatology","volume":"38","author":"Bertolazzi","year":"2019","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.rdc.2023.01.013_bib47","doi-asserted-by":"crossref","first-page":"102394","DOI":"10.1016\/j.autrev.2019.102394","article-title":"Fast track algorithm: how to differentiate a \"scleroderma pattern\" from a \"non-scleroderma pattern","volume":"18","author":"Smith","year":"2019","journal-title":"Autoimmun Rev"},{"issue":"Suppl 125","key":"10.1016\/j.rdc.2023.01.013_bib48","first-page":"132","article-title":"Consensus-based evaluation of dermatoscopy versus nailfold videocapillaroscopy in Raynaud's phenomenon linking USA and Europe: a European League against Rheumatism study group on microcirculation in rheumatic diseases Project","volume":"38","author":"Radic","year":"2020","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.rdc.2023.01.013_bib49","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1093\/rheumatology\/keaa457","article-title":"Reporting items for capillaroscopy in clinical research on musculoskeletal diseases: a systematic review and international Delphi consensus","volume":"60","author":"Ingegnoli","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.rdc.2023.01.013_bib50","first-page":"850","article-title":"Integration of capillary microscopy and dermoscopy into the rheumatology fellow curriculum","volume":"35","author":"Hatzis","year":"2017","journal-title":"Clin Exp Rheumatol"},{"issue":"S119","key":"10.1016\/j.rdc.2023.01.013_bib51","first-page":"151","article-title":"Results from an American pilot survey among Scleroderma Clinical Trials consortium members on capillaroscopy use and how to best implement nailfold capillaroscopy training","volume":"37","author":"Snow","year":"2019","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.rdc.2023.01.013_bib52","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s10067-018-4041-2","article-title":"Can nailfold videocapillaroscopy images be interpreted reliably by different observers? Results of an inter-reader and intra-reader exercise among rheumatologists with different experience in this field","volume":"38","author":"Rodriguez-Reyna","year":"2019","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.rdc.2023.01.013_bib53","first-page":"843","article-title":"Rheumatology education in Europe: results of a survey of young rheumatologists","volume":"29","author":"Bandinelli","year":"2011","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.rdc.2023.01.013_bib54","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1136\/ard.58.3.133","article-title":"Guidelines for rheumatology undergraduate core curriculum","volume":"58","author":"Doherti","year":"1999","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2023.01.013_bib55","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1136\/ard.2007.082867","article-title":"UEMS charter on the training of rheumatologists in Europe","volume":"67","author":"Da Silva","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2023.01.013_bib56","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/s41584-021-00685-0","article-title":"Detection of microvascular changes in systemic sclerosis and other rheumatic diseases","volume":"17","author":"Cutolo","year":"2021","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.rdc.2023.01.013_bib57","doi-asserted-by":"crossref","first-page":"e000782","DOI":"10.1136\/rmdopen-2018-000782","article-title":"Systemic sclerosis: state of the art on clinical practice guidelines","volume":"4","author":"Smith","year":"2018","journal-title":"RMD open"},{"issue":"Suppl 134","key":"10.1016\/j.rdc.2023.01.013_bib58","doi-asserted-by":"crossref","first-page":"3","DOI":"10.55563\/clinexprheumatol\/d2qz38","article-title":"The added value of a European Reference Network on rare and complex connective tissue and musculoskeletal diseases: insights after the first 5 years of the ERN ReCONNET","volume":"40","author":"Talarico","year":"2022","journal-title":"Clin Exp Rheumatol"},{"issue":"Suppl 1","key":"10.1016\/j.rdc.2023.01.013_bib59","doi-asserted-by":"crossref","first-page":"e000791","DOI":"10.1136\/rmdopen-2018-000791","article-title":"Clinical practice guidelines: the first year of activity of the European Reference Network on Rare and Complex Connective Tissue and Musculoskeletal Diseases (ERN ReCONNET)","volume":"4","author":"Mosca","year":"2018","journal-title":"RMD Open"}],"container-title":["Rheumatic Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X23000133?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X23000133?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T11:33:21Z","timestamp":1760182401000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889857X23000133"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":59,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S0889857X23000133"],"URL":"https:\/\/doi.org\/10.1016\/j.rdc.2023.01.013","relation":{},"ISSN":["0889-857X"],"issn-type":[{"type":"print","value":"0889-857X"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Training the Next Generation of Rheumatologists","name":"articletitle","label":"Article Title"},{"value":"Rheumatic Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rdc.2023.01.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}